Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 5,486,526 $ 1,186,033
Short-term investments, restricted 294,802 585,702
Accounts receivable, net 5,286,863 4,750,437
Unbilled revenue 1,072,391 696,912
Inventory, net 5,683,043 4,090,221
Due from related party 1,177,261 600,251
Deferred financing costs 48,989 50,201
Prepaid and other current assets 353,105 348,868
Total current assets 19,402,980 12,308,625
Property, plant and equipment, net 543,754 658,421
Deferred Finance Costs, Noncurrent, Net 0 48,990
Intangible assets, net 1,044,611 1,011,300
Goodwill 40,870 40,870
Other assets 58,425 53,325
TOTAL ASSETS 21,090,640 14,121,531
Current liabilities:    
Accounts payable 3,311,809 2,416,313
Accrued expenses 1,066,860 1,008,153
Deferred revenue 996,941 1,666,576
Total current liabilities 5,375,610 5,091,042
Long-term liabilities:    
Deferred revenue, net of current portion 273,162 207,153
Convertible Debentures, Related Parties, Noncurrent 3,000,000 3,000,000
Total liabilities $ 8,648,772 $ 8,298,195
Commitments and contingencies (Note 8)
Tecogen Inc. shareholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized; 18,478,990 and 15,905,881 issued and outstanding at December 31, 2015 and 2014, respectively $ 18,479 $ 15,906
Additional paid-in capital 34,501,640 25,088,213
Accumulated deficit (21,682,437) (18,955,023)
Total Tecogen Inc. stockholders’ equity 12,837,682 6,149,096
Noncontrolling interest (395,814) (325,760)
Total stockholders’ equity 12,441,868 5,823,336
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 21,090,640 $ 14,121,531